Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Senthil Rajappa

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
JCO Global Oncology|April 11, 2022
Clinical Benefit of Comprehensive Genomic Profiling for Advanced Cancers in IndiaAju Mathew, Serena Joseph, Jeffrey Boby, et al.
Indian Journal of Cancer|March 28, 2022
CONCORDANCE: A real-world evidence study to evaluate the concordance of detecting epidermal growth factor receptor (EGFR) mutation by circulating tumor DNA* versus tissue biopsy in patients with metastatic non-small cell lung cancerKumar Prabhash, Bivas Biswas, Sachin Khurana, et al.
Journal of Surgical Oncology|March 2, 2021
Influence of neoadjuvant therapy on outcomes in patients with resectable carcinoma of esophagus and gastro-esophageal junction from a tertiary cancer care center in IndiaSubramanyeshwar Rao T, Kalidindi Venkata Vijaya Narsimha Raju, Sujit Chyau Patnaik, et al.
BMC Cancer|July 31, 2023
Consensus guidelines for the management of HR-positive HER2/neu negative early breast cancer in India, SAARC region and other LMIC by DELPHI survey methodPurvish Parikh, Govind Babu, Randeep Singh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2026
Bladder Adjuvant Radiotherapy: Phase III Multicenter Randomized Controlled Trial of Adjuvant Radiotherapy or Observation for Postcystectomy Muscle-Invasive Bladder CancerVedang Murthy, Priyamvada Maitre, Mahendra Pal, et al.
South Asian Journal of Cancer|March 24, 2025
Consensus Guidelines for the Use of Cyclin-Dependent Kinase (CDK) 4/6 Inhibitors in the Management of Hormone Receptor Positive (HR+ve), Her2-ve Early Breast Cancer (EBC)Purvish M Parikh, Amish Vora, Rajan Yadav, et al.
Oncology Letters|August 22, 2018
Novel formulations of docetaxel, paclitaxel and doxorubicin in the management of metastatic breast cancerSenthil Rajappa, Ashish Joshi, Dinesh C Doval, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2023
Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive Lung CancersJulia Rotow, Jyoti D Patel, Matthew P Hanley, et al.
Oncology and Therapy|October 17, 2025
A Decade of Treating ALK-Rearranged Non-Small Cell Lung Cancer in a Lower Middle-Income Country: Changing Patterns and Improving SurvivalUllas Batra, Mansi Sharma, Irfan Ahmad, et al.
Cancer Epidemiology|August 2, 2024
Prevalence and types of cancer in older Indians: A multicentric observational study across 17 institutions in IndiaVanita Noronha, Abhijith Rajaram Rao, Anupa Pillai, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
JCO Global Oncology|April 11, 2022
Clinical Benefit of Comprehensive Genomic Profiling for Advanced Cancers in IndiaAju Mathew, Serena Joseph, Jeffrey Boby, et al.
Indian Journal of Cancer|March 28, 2022
CONCORDANCE: A real-world evidence study to evaluate the concordance of detecting epidermal growth factor receptor (EGFR) mutation by circulating tumor DNA* versus tissue biopsy in patients with metastatic non-small cell lung cancerKumar Prabhash, Bivas Biswas, Sachin Khurana, et al.
Journal of Surgical Oncology|March 2, 2021
Influence of neoadjuvant therapy on outcomes in patients with resectable carcinoma of esophagus and gastro-esophageal junction from a tertiary cancer care center in IndiaSubramanyeshwar Rao T, Kalidindi Venkata Vijaya Narsimha Raju, Sujit Chyau Patnaik, et al.
BMC Cancer|July 31, 2023
Consensus guidelines for the management of HR-positive HER2/neu negative early breast cancer in India, SAARC region and other LMIC by DELPHI survey methodPurvish Parikh, Govind Babu, Randeep Singh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2026
Bladder Adjuvant Radiotherapy: Phase III Multicenter Randomized Controlled Trial of Adjuvant Radiotherapy or Observation for Postcystectomy Muscle-Invasive Bladder CancerVedang Murthy, Priyamvada Maitre, Mahendra Pal, et al.
South Asian Journal of Cancer|March 24, 2025
Consensus Guidelines for the Use of Cyclin-Dependent Kinase (CDK) 4/6 Inhibitors in the Management of Hormone Receptor Positive (HR+ve), Her2-ve Early Breast Cancer (EBC)Purvish M Parikh, Amish Vora, Rajan Yadav, et al.
Oncology Letters|August 22, 2018
Novel formulations of docetaxel, paclitaxel and doxorubicin in the management of metastatic breast cancerSenthil Rajappa, Ashish Joshi, Dinesh C Doval, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2023
Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive Lung CancersJulia Rotow, Jyoti D Patel, Matthew P Hanley, et al.
Oncology and Therapy|October 17, 2025
A Decade of Treating ALK-Rearranged Non-Small Cell Lung Cancer in a Lower Middle-Income Country: Changing Patterns and Improving SurvivalUllas Batra, Mansi Sharma, Irfan Ahmad, et al.
Cancer Epidemiology|August 2, 2024
Prevalence and types of cancer in older Indians: A multicentric observational study across 17 institutions in IndiaVanita Noronha, Abhijith Rajaram Rao, Anupa Pillai, et al.
Pageof 6